Newsroom

Industry News

14 Oct

Intellipharmaceutics Announces Third Quarter 2016 Results

TORONTO, Oct. 13, 2016 (GLOBE NEWSWIRE) — Intellipharmaceutics International Inc. (IPCI) (TSX:I) (“Intellipharmaceutics” or the “Company”), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs, today reported the results of operations for the three and nine months...

Read more

14 Oct

Abeona Therapeutics to Present Top-Line Data of Low-Dose Cohort for ABO-102 in Phase 1/2 Clinical Trial for MPS IIIA Patients at Upcoming Orphan Drugs and Rare Disease Congress October 19-20th in London, UK

NEW YORK, NY and CLEVELAND, OH–(Marketwired – October 14, 2016) – Abeona Therapeutics Inc. (ABEO), a clinical-stage biopharmaceutical company focused on developing gene therapies for life-threatening rare diseases, announced today that top-line results of the low-dose cohort for ABO-102 in Phase 1/2 clinical trial for Sanfilippo type A (MPS...

Read more

14 Oct

Intellipharmaceutics to Present at Dawson James Securities Growth Stock Conference

TORONTO, Oct. 14, 2016 (GLOBE NEWSWIRE) — Intellipharmaceutics International Inc. (IPCI) (TSX:I) (“Intellipharmaceutics” or the “Company”), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs, today announced that the Company is scheduled to present at the Dawson James...

Read more

13 Oct

Monster Digital, Inc. Launches Virtual Reality (VR) Action Sports Camera Line

SIMI VALLEY, CA / ACCESSWIRE / October 13, 2016 / Monster Digital, Inc. (MSDI) (“Monster Digital” or the “Company”), which develops, markets and distributes Monster branded products for use in high-performance consumer electronics, mobile products and computing applications, today announced the launch of its virtual reality action sports camera...

Read more

13 Oct

Check-Cap Announces Upcoming Presentations Evaluating Preparation-Free Colorectal Cancer Screening Capsule

ISFIYA, Israel, Oct. 13, 2016 /PRNewswire/ — Check-Cap Ltd. (Nasdaq:  CHEK, CHEKW), a clinical stage medical diagnostics company, today announced upcoming presentations evaluating the Company’s ingestible capsule for preparation-free, colorectal cancer screening. Presentations will take place at the American College of Gastroenterology (ACG) Annual Scientific Meeting taking place October 14-19,...

Read more

13 Oct

Onconova Therapeutics, Inc. to Present Corporate Update at 2016 BIO Investor Forum

NEWTOWN, Pa., Oct. 13, 2016 (GLOBE NEWSWIRE) — Onconova Therapeutics, Inc. (ONTX), a Phase 3 clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, today announced that Ramesh Kumar, Ph.D., President and Chief Executive Officer, will present a company update at the 2016 BIO Investor...

Read more

13 Oct

Cellectar Biosciences To Present at BIO Investor Forum

MADISON, Wis., Oct. 13, 2016 (GLOBE NEWSWIRE) — Cellectar Biosciences, Inc. (CLRB) (the “company”), an oncology-focused, clinical stage biotechnology company, today announces that Jarrod Longcor, senior vice president of corporate development and operations, will present at the BIO Investor Forum in San Francisco on October 18, 2016. The company’s...

Read more

13 Oct

Monster Digital, Inc. Launches Virtual Reality (VR) Action Sports Camera Line

Portfolio Bolstered with 3600 Monster Vision™ VR Camera as well as Monster Vision™ 1080p+ Camera SIMI VALLEY, CA / ACCESSWIRE / October 13, 2016 / Monster Digital, Inc. (MSDI) (“Monster Digital” or the “Company”), which develops, markets and distributes Monster branded products for use in high-performance consumer electronics, mobile...

Read more

12 Oct

Intellipharmaceutics Signs an Exclusive License and Commercial Supply Agreement with Mallinckrodt

TORONTO, Oct. 11, 2016 (GLOBE NEWSWIRE) — Intellipharmaceutics International Inc. (IPCI) (TSX:I) (“Intellipharmaceutics” or the “Company”), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs, today announced that it has entered into a license and commercial supply...

Read more

Page 30 of 216« First...1020...2829303132...405060...Last »

Enter your email address to receive notifications of new posts by email.

Latest Tweets

Follow

Follow this blog

Get every new post delivered right to your inbox.

Email address